Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.7M Sell
162,990
-6,560
-4% -$1.87M 11% 1
2026
Q1
$29.4M Buy
169,550
+56,050
+49% +$11.5M 6.29% 8
2025
Q4
$29.1M Buy
113,500
+21,300
+23% +$5.58M 4.7% 10
2025
Q3
$24M Hold
92,200
4.62% 8
2025
Q2
$22.5M Sell
92,200
-11,400
-11% -$2.84M 3.92% 10
2025
Q1
$27.4M Buy
103,600
+99,200
+2,255% +$26.8M 5.08% 12
2024
Q4
$1.12M Buy
+4,400
New +$1.18M 0.22% 22
2024
Q3
Sell
-199,800
Closed -$74.7M 21
2024
Q2
$74.7M Buy
199,800
+65,000
+48% +$21.9M 12.16% 1
2024
Q1
$46.7M Buy
134,800
+68,600
+104% +$26M 7.74% 3
2023
Q4
$30.3M Buy
+66,200
New +$32.6M 4.26% 12
2023
Q1
Sell
-45,300
Closed -$23.2M 25
2022
Q4
$23.2M Hold
45,300
5.2% 7
2022
Q3
$22M Hold
45,300
3.95% 11
2022
Q2
$21.2M Hold
45,300
3.91% 10
2022
Q1
$19.7M Buy
+45,300
New +$18.9M 4.26% 11

Other funds holding HUM

Solel Partners's HUM Position: Q2 2026 in Review

Solel Partners reduced its Humana (HUM) stake by 3.9% in Q2 2026, selling an estimated $1.87M and leaving 162,990 shares worth $64.7M. The position accounts for 11% of the portfolio, ranked #1.

Solel Partners first reported a position in HUM in Q1 2022 and has held it in 14 quarters since. The position peaked at $74.7M in Q2 2024. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Solel Partners held 162,990 shares of Humana worth $64.7M as of Q2 2026.
  • Solel Partners sold 6,560 Humana shares in Q2 2026, an estimated $1.87M.
  • Humana made up 11% of Solel Partners's portfolio in Q2 2026, its #1 holding.
  • Solel Partners first reported a position in Humana in Q1 2022 and has held it in 14 quarters since.
  • Solel Partners's Humana position peaked at $74.7M in Q2 2024.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Solel Partners's 13F filing for Q2 2026, filed 14 Aug 2026.